COMP <GO>
STE vs MRK // 10Y YIELD & FRED MACRO BETA
STERIS plc (Ireland) (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: STE 6
— MRK 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: STE
LAST: $227.12 (-2.16%) • MKT CAP: $22.63B
macro-sensitivity
1.08
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STE VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STE | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 44.20% | 74.80% | -30.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.10% | 20.70% | -10.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 15.3x | +1.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.30% | 3.42% | +0.88 | STE | /fcf-yield <GO> |
| Operating Margin | 18.60% | 34.30% | -15.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | 13.20% | 28.10% | -14.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 8.70% | 1.30% | +7.40 | STE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 2.26% | -1.19 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.40 | 5.19 | +0.21 | STE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | STE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.60% | +0.60 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.9 | 56.9 | +0.04 | STE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 0.92 | +0.16 | STE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.9x | 18.4x | +8.50 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.63B | $361.02B | -$338.39B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STE REV | MRK REV | STE GROSS % | MRK GROSS % | STE FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.94B | $65.01B | 44.2% | 74.8% | $972.4M | $12.36B |
| FY 2024 | $5.46B | $64.17B | 44.0% | 76.3% | $778.0M | $18.10B |
| FY 2023 | $5.14B | $60.12B | 44.0% | 44.0% | $742.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STE // BETA 1.08
MRK // BETA 0.92